Concepedia

David Sarkar

DS

Statistics

Publications

9

Citations

967

H-Index

9

Active since

1999

Affiliations

Leiden University Medical Center(Current)

Hôpital Bichat-Claude-Bernard

Assistance Publique – Hôpitaux de Paris

Auckland City Hospital

Université Paris Cité

David Sarkar is an author at Leiden University Medical Center specializing in medicine, pharmacology, and cardiology.

Publications per year

1999–2022

9

Publications

9

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

, , +15

Comparison of Long-Term Outcomes of Atrial Repair of Simple Transposition With Implications for a Late Arterial Switch Strategy

David Sarkar, Catherine Bull, Robert Yates et al. · Circulation · 1999 · 145 citations

, , +9

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

, , +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

, , +17

Protease-Activated Receptor-2 Activation Causes EDHF-Like Coronary Vasodilation

Peter G. McLean, Daniel Aston, David Sarkar et al. · Circulation Research · 2002 · 93 citations · Full text

, , +8

1–5 of 9